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Abstract The possibility of coexistence of di¡erent subtypes of
membrane lipid rafts has been investigated in cerebellar granule
cells, by submitting detergent-resistant membrane fractions to
immunoprecipitation. Among the proteins and lipids present in
detergent-resistant fractions, almost all Prion protein, GAP43
and PKC were present in the immunoprecipitate obtained with
anti-GAP43 or anti-Prion protein antibody at 4‡C, together
with a small fraction of cholesterol and sphingolipids, suggesting
that they belong to a distinct subset of membranes. On the
contrary, all Fyn and almost all MARCKS remained in the
supernatant. Fluorescence microscopy experiments showed that
Fyn and Prion protein were mostly not colocalized within a
single neuron. Our results suggest that granule cells membranes
contains di¡erent subtypes of detergent-resistant fractions, pos-
sibly deriving from di¡erent lipid rafts.
* 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The concept that cell membranes are heterogeneous struc-
tures containing lipid microdomains, having a composition
distinct from that of the bulk membrane, is generally ac-
cepted. A particular type of domains are lipid rafts, sphingo-
lipid- and cholesterol-enriched structures involved in the mod-
ulation of fundamental events at the level of cell membranes
[1]. The experimental clues of the existence of lipid rafts are
considered to be the detergent-resistant membrane fractions
(DRM), which can be separated at cold, and on the basis of
their lower density by sucrose gradient centrifugation, and
enriched in speci¢c, often lipid-modi¢ed proteins [2].
The possibility of coexistence of di¡erent membrane do-
mains, performing di¡erent biological functions within the
same cell, has been already ascertained. Most of the informa-
tion available on this topic is concerning the coexistence of
caveolae besides non-caveolar domains [3,4]. For instance,
such a proof has been obtained in endothelial cells using im-
muno£uorescence confocal microscopy and immunoprecipita-
tion techniques [3,5], in MDCK cells and human ¢broblasts
using electron microscopy [4], and in human intestinal epithe-
lial cells [6] by selective immunoprecipitation with anti-glyco-
sphingolipid antibodies.
An intriguing possibility that has been only partially inves-
tigated is whether or not di¡erent non-caveolar lipid rafts may
coexist within the same cell. Some clues support this possibil-
ity: for instance, in model membranes distinct sphingolipid-
enriched domains are detectable [7] ; rabbit brain microsomal
membranes contain di¡erent coexisting pools composed of
ganglioside molecular species carrying di¡erent ceramide com-
positions [8]. We decided to utilize rat cerebellar granule cells
(CGCs) di¡erentiated in culture to investigate the coexistence
of di¡erent non-caveolar membrane lipid rafts. In fact, in
these cells, the presence of DRM has been repeatedly ascer-
tained [9^12] while, concerning caveolae, their presence in
CGCs, as in general in di¡erentiated neurons, seems to be
excluded [12^15]. In this work we show that at least two sub-
types of DRM, having di¡erent protein and lipid composi-
tions, are coexisting in CGC membranes.
2. Materials and methods
2.1. Chemicals
The reagents used (analytical grade) and HPTLC plates (Kieselgel
60) were purchased from Merck GmbH (Darmstadt, Germany).
Modi¢ed Eagle’s basal medium, fetal calf serum, trypsin, CAPS (3-
[cyclohexylamino]1-propanesulfonic acid), 2-[N-morpholino]ethansul-
fonic acid (MES), and antibody against GAP43 were from Sigma
Chem. Co. (Milano, Italy).
Primary antibodies against Fyn (sc-434), against MARCKS (sc-
6455) and against Prion protein (PrPC) (sc-7693) were from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). All the materials for
the electrophoresis were from BioRad (Milano, Italy).
Secondary antibodies for immuno£uorescence microscopy were
Texas-Red donkey anti-goat and FITC donkey anti-mouse (Jackson
Immunoresearch Lab, PA, USA). Secondary antibodies for enhanced
chemiluminescence (ECL) detection were mouse and/or goat-HRP
conjugates (Pierce).
2.2. Cell cultures
Granule cells, obtained from the cerebella of 8-day-old Sprague^
Dawley rats (Charles River, Milan, Italy), were prepared as described
[16,17]. Proliferation of glial cells was prevented by adding cytosine
arabinofuranoside (¢nal concentration, 10 WM) and checked by mi-
croscopic examination. Cell morphology was followed by microscopic
examination and cell viability was monitored with £uorescein diace-
tate and propidium iodide [17]. The experiments were performed with
cells cultured for 8 days in vitro (DIV). The protein content was
determined with the micro BCA assay from Sigma Chem. Co. (Mila-
no, Italy).
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2.3. Preparation and characterization of DRM
Cells at 8 DIV were cultured in 100 mm dishes, washed two times,
harvested in Locke’s solution and submitted to centrifugation. In
order to maintain a constant protein/detergent ratio, a cell pellet cor-
responding to 2.5 mg cellular proteins was incubated in 2 ml of 1%
Triton X-100 in 25 mM MES bu¡er, pH 6.5, containing 150 mM
NaCl, 1 mM phenylmethylsulfonyl £uoride (PMSF) and 75 units/ml
aprotinin (MBS bu¡er), for 30 min on ice. The cell lysate was sub-
mitted to discontinuous sucrose density gradient centrifugation, as
described [11,12]. Brie£y, the cell lysate (2 ml) was diluted with an
equal volume of 80% (w/v) sucrose in MBS lacking Triton X-100 and
placed at the bottom of a discontinuous (30^5%, 4 ml each) sucrose
concentration gradient in MBS without Triton X-100. After centrifu-
gation at 250 000Ug for 18 h at 4‡C, 1 ml fractions were collected and
submitted to further analysis. From now on, to fraction #5 from the
top they will be referred as DRM (detergent-resistant membrane frac-
tion), to fractions from #9 to 12 as HDF (high density membrane
fraction).
2.4. Radiolabeling of cell sphingolipids
Cells were incubated in the presence of 1039 M [3-3H]sphingosine
(speci¢c activity, 15 Ci/mmol, PerkinElmer Life Science), 5 ml/dish, in
cell-conditioned medium for 2 h (pulse) followed by 48 h chase, ac-
cording to Prinetti et al. [9]. DRM from [3-3H]sphingosine-fed cells
were prepared following the Triton X-100 method above described.
2.5. Immunoprecipitation experiments
All the following protocols were performed at 4‡C. Aliquots of
DRM (900 Wl) obtained from di¡erent treatments were diluted 10-
fold in immunoprecipitation bu¡er (IB) containing 50 mM Tris^
HCl, pH 7.4, 150 mM NaCl, 2 mM NaF, 1 mM EDTA, 1 mM
EGTA, 1 mM Na3VO4, 1 mM PMSF, 75 mU/ml Leupeptin, 1%
Triton X-100, precleared by incubation with 50 Wl of protein G-
coupled magnetic beads (Dynabeads Protein G) and placed in a ro-
tary mixer for 2 h. To the supernatant, after separation of beads, was
added 10 Wg/ml anti GAP43, or 10 Wg/ml anti-PrPc, or 10 Wg/ml
normal mouse IgG (as negative control) and the mixtures stirred over-
night at 4‡C. Immunoprecipitates (IP) were recovered using 50 Wl
protein G-coupled magnetic beads for 4 h at 4‡C, washed three times
with IB bu¡er, recovered and suspended in Laemmli bu¡er. Fifty Wl
of the total supernatants (9 ml), remaining after immunoprecipitation,
was dialyzed, lyophilized and suspended in Laemmli bu¡er.
In some comparative experiments, aliquots of the DRM were di-
luted in the above IB bu¡er and incubated at 37‡C for 30 min to
allow the desegregations of the sphingolipids-enriched domain [2,18]
before performing the immunoprecipitation as described above.
Proteins in DRM, IP and in corresponding supernatants were sep-
arated by sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and transferred to nitrocellulose membranes. After
blocking with 5% non-fat milk in phosphate-bu¡ered saline (PBS)
containing 0.1% Tween 20, blots were incubated in the presence of
antibody (anti-PKC 1:200, anti-Fyn 1:250, anti-PrPc 1:500, anti-
GAP43 1:500, anti-MARCKS 1:500), followed by reaction with sec-
ondary HRP-conjugates and ECL detection (Pierce Supersignal). The
ECL ¢lm was submitted to densitometric scan. The digitized values of
the spot corresponding to a given protein were utilized to express its
partitioning between DRM and HDF as follows:
Partitioning ¼
digitized value in DRMU100
average digitized values in HDFþ digitized value in DRM
2.6. Lipid analysis
Lipids were extracted from IP and from the corresponding super-
natants lyophilized, with chloroform/methanol 2:1 (v/v). Total ex-
tracts obtained from IP and 1/100 of the extract of the corresponding
supernatants were analyzed by HPTLC. In the case of sphingolipid
analysis, the solvent system was chloroform/methanol/0.2% aqueous
CaCl2 (55/45/10, v/v/v), followed by radioactivity imaging (Beta-Im-
ager 2000 Z Instrument; Biospace, Paris, France). For cholesterol
analysis, the extracted lipid samples were separated by HPTLC (sol-
vent system hexane/diethylether/acetic acid 20/35/1, v/v/v) and then
sprayed with anisaldehyde reagent. After heating the plate at 180‡C
for 5 min, the HPTLC plates were submitted to densitometric scan-
ning. Quanti¢cation was made on the basis of known amounts of
standard lipids loaded on the same plate.
2.7. Immuno£uorescence microscopy
Cells grown on cover glasses were ¢xed for 10 min with methanol at
320‡C, treated brie£y with 0.1 M glycine in PBS (pH 7.4) followed by
0.3% Triton X-100, 15% ¢ltered goat serum, 0.45 M NaCl, and 10
mM phosphate bu¡er, pH 7.4. Cover glasses were then incubated
overnight at 4‡C with primary antibodies (1:4), washed, and incuba-
ted for 1 h at room temperature with the appropriate conjugates sec-
ondary antibodies (1:100). Fyn was immunolocalized with the FITC-
conjugated antibody. PrPc was localized using the Texas-Red-conju-
gated antibody. Following a ¢nal washing, cover glasses were
mounted with glycerol. Confocal microscopy was carried out on a
Radiance 2100 microscope (Biorad Laboratories, Hercules, CA,
USA) equipped with a krypton/argon laser; noise reduction was
achieved by Kalman ¢ltering during acquisition.
3. Results
Rat CGCs were submitted to the isolation of DRM. The
evaluation of partitioning between DRM and HDF of Fyn,
PrPC, GAP43, PKC and MARCKS, calculated as described
above, gave ¢gures of 100, 100, 80, 30 and 15, respectively
(Fig. 1), indicating that almost all cellular Fyn and PrPC are
concentrated in DRM, while only a smaller but signi¢cant
portion of the other proteins is present in this fraction. It is
worth noting that in the case of GAP43 and MARCKS, and
di¡erently from PKC, a signi¢cant amount of these proteins is
also present in fractions having an intermediate density be-
tween DRM and HDF. It will be interesting to deepen the
origin of this behavior.
Fig. 1. Immunoblot analysis of PKC, GAP43, MARCKS, PrPc and
Fyn of sucrose gradient fractions, obtained from CGCs after treat-
ment with 1% Triton X-100 at 4‡C, and submitted to 10% SDS^
PAGE. Except for fractions 1^3, which were pooled, for each frac-
tion 5 Wg protein/lane was loaded. The upper panel shows the pro-
tein distribution (diamonds) (% in each fraction) and the sucrose
step gradient utilized (triangles).
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Successively, we analyzed the composition of IP obtained
from DRM using antibodies against GAP43 (Fig. 2A). The IP
proteins were submitted to electrophoresis and immunoblot-
ting with anti-PrPc, PKC, Fyn and MARCKS antibodies. The
results show that all PrPC and all PKC present in DRM were
detected in the IP (lane 1). On the contrary, almost all Fyn
and the major part of MARCKS present in DRM were re-
covered in the supernatant (lane 2). GAP43 was not detected
in this supernatant (data not shown), indicating that all of this
protein was in the IP. Control of protein G-coupled magnetic
beads used to preclear (lane 3) indicated that immunoprecip-
itation was speci¢c.
To con¢rm these results, we used antibody against PrPC for
immunoprecipitation of DRM (Fig. 2B). The results show
that the IP obtained with anti-PrPC (lane 4) contained all
GAP43 and PKC present in DRM. On the contrary, almost
all Fyn and the major part of MARCKS (about 95%, as
calculated after correction for the amount of protein loaded
on the electrophoresis) remained in the supernatant (lane 5).
In this latter supernatant PrPC was not detected (data not
shown), indicating that all of this protein was in the IP.
To con¢rm that the information obtained by immunopre-
cipitation with anti-GAP43 or anti-PrPC was due to the spe-
ci¢c interaction of the antibody with the protein present in the
domain, DRM was immunoprecipitated at 4‡C with normal
mouse IgG (Fig. 3, lanes 1 and 2) or with goat IgG (data not
shown). Under these conditions none of the above said pro-
teins was detected in the IP (lane 1), but remained in the
supernatant (lane 2).
Additional experiments were performed under conditions
that do not preserve the membrane resistance to detergents:
DRM was warmed at 37‡C, 20 min, before performing the
immunoprecipitation using anti-GAP43. Fig. 3 (lanes 3 and 4)
shows that under these conditions, PKC, MARCKS, Fyn,
and PrPC were not detected in the IP.
As concerning the lipid composition of IP, the cholesterol
content was analyzed by HPTLC of total lipid extracts from
the IP. After comparison with standard cholesterol loaded on
the plate and after correction for the amount of extract
loaded, it was calculated that cholesterol present in IP was
about 2.5% of the total DRM cholesterol.
To assess the sphingolipid content, total lipid extracts of the
IP obtained from cells previously incubated in the presence of
[3-3H]sphingosine were analyzed by TLC. In Table 1 is re-
ported the pattern of radioactive lipids present in DRM, in
the IP and in the corresponding supernatant. The radioactive
lipids pattern of IP shows small di¡erences with respect to
DRM, with a decrease of the proportion of sphingomyelin
and an increase of GT1b ganglioside. Taking into account
the total amount of radioactivity in DRM (about 200 000
dpm), in the IP (about 13 000 dpm) and in the corresponding
Fig. 2. Immunoblot analysis of PKC, GAP43, MARCKS, PrPc and
Fyn in IP obtained from detergent-resistant membranes using anti-
GAP43 (panel A) or anti-PrPc (panel B) antibodies at 4‡C, and sub-
mitted to 10% SDS^PAGE. A: Lane 1, proteins associated with the
IP; lane 2, proteins remaining in the corresponding supernatant;
lane 3, proteins associated with G-coupled magnetic beads used to
preclear the sample. B: Lane 4, proteins associated with the IP;
lane 5, proteins remaining in the corresponding supernatant.
Fig. 3. Immunoblot analysis of PKC, MARCKS, PrPc and Fyn of
IP obtained from detergent-resistant membranes under di¡erent ex-
perimental conditions. Proteins associated with the IP (lane 1) and
in the corresponding supernatant (lane 2), using normal mouse IgG
at 4‡C. Proteins associated with the IP (lane 3) and in the corre-
sponding supernatant (lane 4) using anti-GAP43 at 37‡C.
Table 1
Sphingolipid composition of detergent-resistant membranes (DRM),
of immunoprecipitates (IP) and corresponding supernatants (SIP)
obtained from DRM with anti-GAP43 antibody
DRM IP SIP
SM 24.7 16.1 20.3
GM1 10.8 9.7 10.6
GD3 9.8 9.3 12.3
GD1a 14.8 15.4 16.8
GD1b 18 18.9 18.1
GT1b 22.1 30.4 22.2
Radioactive lipids were extracted and separated by HPTLC in the
solvent system chloroform/methanol/0.2% aqueous CaCl2 (55/45/10,
v/v/v). Radioactive lipids were detected by digital autoradiography.
Data are expressed as percent of radioactivity carried by each lipid
over the total radioactivity present in each fraction.
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supernatant (about 173 000 dpm), it was calculated that the
amount of sphingolipids present in the ‘Prion domain’ is about
6.5% of the total present in DRM. Control experiments car-
ried out at 4‡C with normal mouse IgG showed that under
these conditions all the radioactivity was not in the IP, but in
the corresponding supernatant (data not shown).
Finally, immuno£uorescence confocal microscopy experi-
ments were carried out with anti-Fyn and anti-PrPC antibod-
ies (Fig. 4). The observation at low magni¢cation of a single
cell showed a scattered distribution of both proteins at any
cell level, nucleus excluded (Fig. 4A,B). Merged confocal sec-
tions (Fig. 4C) showed that Fyn and PrPc are only partially
colocalized. Observation at a larger magni¢cation (Fig. 4AP^
CP) allowed to establish that the two proteins are mostly not
colocalized.
4. Discussion
The aim of the present study was to assess the presence in
CGCs of di¡erent subtypes of lipid rafts having di¡erent pro-
tein and/or lipid composition. We chose this cellular system
since caveolin has not been detected in CGC [12] and the
protein and lipid composition of non-caveolar DRM isolated
from these cells has been previously characterized [9^12,18].
The present investigation suggests that in DRM of CGC, at
least two types of detergent-resistant membranes are present.
The experimental support of this evidence is given by experi-
ments carried out on DRM with antibodies against PrPc and
GAP43, showing coimmunoprecipitation of PrPc and GAP43,
and exclusion of Fyn and MARCKS from the IP.
Immuno£uorescence confocal microscopy observations at a
large magni¢cation of zones where the cell is presumably
thinner and where it is easier to discriminate among di¡erent
membranes established that Fyn with PrPc are present within
the same cell and are mostly not colocalized. Parallel experi-
ments carried out under conditions that do not preserve the
integrity of domains, or using non-speci¢c antibodies, indi-
cated that the IP were speci¢c. The compositional analysis
showed all PrPc, GAP43 and PKC contained in DRM were
present in the IP, suggesting that these proteins belong to a
distinct subset of DRM. Since DRM are considered to be the
experimental clues of the existence of lipid rafts [2], these
results suggest the presence in CGC of lipid rafts containing
the above-mentioned proteins, and in particular almost all
cellular PrPC (Prion domains).
Concerning the functional signi¢cance of the colocalization
of PrPc and PKC in the Prion domain, it could be explained
for two reason: ¢rst, PrPc is a substrate of PKC (in vitro) and
the phosphorylation/dephosphorylation cycle might modulate
PrPc biological activity [19]. Second, it was demonstrated that
the physiological cleavage occurring between the 110/111^112
amino acid residues of PrPc, is upregulated by e¡ectors of the
PKC pathway [20]. Also the GAP43 enrichment within the
Prion domain could have a functional signi¢cance, since
GAP43 in CGCs is a preferential substrate of PKC, and the
amount of phosphorylated GAP43 promotes and regulates
cell-surface dynamics, phagocytosis, cell attachment and regu-
lated morphogenic processes such as neurite outgrowth [21].
Concerning the relative contribution of the Prion domain to
DRM, it can be speculated that this domain represents only a
minor portion of DRM, since the IP contained only a small
portion of DRM cholesterol and sphingolipids, with a signi¢-
cant di¡erence in the sphingolipid pattern. However, these
issues deserve further investigations.
Regarding other proteins that are present in DRM, almost
all Fyn (which represent virtually all the cellular proteins) and
95% of MARCKS were not in the Prion domain. This result
¢nds a con¢rmation in a previous paper [21], suggesting that
Scr tyrosine kinase are not associated to the GAP43-contain-
ing domain, but we have no further information. In line of
principle, these proteins could be part of one or more other
subsets of DRM. It can be reminded that Kasahara et al. [22]
and Prinetti et al. [18] demonstrated that GD3, cholesterol,
glycosphingolipids and di¡erent Src-proteins (Lyn, Fyn and c-
Fig. 4. Immuno£uorescence microscopy analysis. The cells grown on glass coverslips, after methanol ¢xation, were double stained with the
FITC-conjugated antibody (green, panel A) in the case of Fyn and with the Texas-Red-conjugated (red, panel B) antibody in the case of PrPc.
Merged confocal sections (panel C) showed only a partial colocalization of Fyn with PrPc. Bar, 5 Wm. Enlargement of a cell zone (delimited by
a white line) shows that the two proteins are mostly not colocalized (panel CP). Bar, 5 Wm.
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Scr) are coimmunoprecipitated from CGC by anti-GD3 anti-
body, indicating that these molecules probably share the same
lipid rafts.
In conclusion, our results suggest that di¡erent subtypes of
DRM, presumably deriving from di¡erent lipid rafts, can be
isolated from CGCs.
In particular, it is possible that the ‘Prion domain’ contains
a speci¢c set of signaling components and this restriction
would limit access of the components of other signaling path-
way (i.e. Fyn) and prevent non-speci¢c signaling. The use of
di¡erent antibodies against protein or lipid membrane do-
mains fraction, together with the development of very sensi-
tive analytical procedures, should allow us to obtained new
pieces of information about the properties of di¡erent mem-
brane lipid domains.
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